Osiris Therapeutics Initiates Phase II Clinical Trial Evalu

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Stem Cell Research News
Reply to topic
Osiris Therapeutics Initiates Phase II Clinical Trial Evalu
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Tue May 27, 2008 12:11 pm Reply with quote
Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced the treatment of the first patients in a new Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell (MSC) therapy, for moderate to severe Chronic Obstructive Pulmonary Disease (COPD). This trial marks the sixth indication for which Prochymal has been advanced into Phase II or later-stage clinical trials.

Read more...
View user's profileSend private message
Osiris Therapeutics Initiates Phase II Clinical Trial Evalu
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Stem Cell Research News
 Reply to topic  
Forum Map
Site Map